JPT2/HN1L functions as an NAADP-binding protein in a cell-type specific manner

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Nicotinic acid adenine dinucleotide phosphate (NAADP) is a second messenger evoking Ca²⁺ release from intracellular Ca²⁺ stores by targeting several Ca 2+ channels including two-pore channels (TPC1/2), transient receptor potential mucolipin-1 (TRPML1), or ryanodine receptor type 1 (RYR1). For activation of Ca 2+ channels, NAADP requires binding proteins, such as JPT2/HN1L and LSM12. So far, their function has been analyzed in several cell lines and only a very limited number of primary cells; however, their physiological relevance in cell types known to utilize NAADP signaling remains unclear. Here, we generated JPT2/HN1L-deficient ( Jpt2/Hn1l −/− ) mice to evaluate the contribution of JPT2/HN1L proteins to platelet aggregation, and Ca 2+ signaling in cardiomyocytes, mast cells, and CD4⁺ T cells. NAADP is known to contribute to collagen-related peptide (CRP)-evoked platelet aggregation, but this was not altered by JPT2/HN1L deletion. Functional Ca²⁺ imaging revealed that JPT2/HN1L plays a strikingly cell-type specific role in NAADP-mediated Ca 2+ release. In beating ventricular cardiomyocytes, β-adrenergic stimulation is known to evoke arrhythmogenic spontaneous diastolic Ca 2+ transients, which were not altered in their frequency in Jpt2/Hn1l −/− myocytes. Further, antigen-evoked Ca 2+ transients in peritoneal mast cells (PMCs) are not changed in Jpt2/Hn1l −/− PMCs. However, CD4⁺ T cells displayed a pronounced requirement for JPT2/HN1L. Following T cell receptor/CD3 stimulation, global Ca²⁺ elevations and early NAADP-driven Ca²⁺ microdomains, which occur within tens of milliseconds of TCR/CD3 engagement and serve as initiating signals for downstream immune activation, were significantly decreased in Jpt2/Hn1l −/− CD4 + cells. We conclude that JPT2/HN1L is indispensable for NAADP-mediated Ca²⁺ release in T cells, but dispensable in cardiomyocytes, platelets, and mast cells, at least for the agonists employed. Accordingly, LSM12 might compensate for the loss of JPT2/HN1L. Together, JPT2/HN1L is not universally required as an NAADP-binding protein but exhibits cell-type specificity, with an essential function in T cell Ca²⁺ signaling.

Highlights

  • JPT2/HN1L has been identified as an NAADP-binding protein mediating NAADP-evoked Ca²⁺ release via its target channels TPC1, TPC2and RyR1.

  • We investigated the role of JPT2/HN1L in NAADP-dependent Ca²⁺ signaling across four distinct cell types.

  • NAADP-dependent Ca²⁺ responses were unaltered in JPT2/HN1L -/- cardiomyocytes, platelets, and mast cells.

  • JPT2/HN1L is essential for NAADP-mediated CD4⁺ T-cell receptor activation.

Article activity feed